<HashMap><database>ENA</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR147/047/SRR14712247/SRR14712247.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR147/050/SRR14712250/SRR14712250.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR147/046/SRR14712246/SRR14712246.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR147/049/SRR14712249/SRR14712249.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR147/051/SRR14712251/SRR14712251.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR147/048/SRR14712248/SRR14712248.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR147/053/SRR14712253/SRR14712253.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR147/052/SRR14712252/SRR14712252.fastq.gz</Fastqsanger.gz></files><type>primary</type></body><statusCodeValue>200</statusCodeValue><statusCode>OK</statusCode></file_versions><scores/><additional><omics_type>Genomics</omics_type><center_name>University of Ottawa</center_name><full_dataset_link>https://www.ebi.ac.uk/ena/browser/view/PRJNA734600</full_dataset_link><scientific_name>Homo sapiens</scientific_name><long_description>HT29 cells were exposed to EC50 doses of reverse-turn peptidomimetic molecules ICG-001, CWP232228, and YB-0158 (vs. vehicle control DMSO) over 48 hours. RNA sequencing profiling was performed for each experimental condition. Overall design: Whole transcriptome profiling</long_description><tag>xref:PubMed:34877499</tag><repository>ENA</repository><name_synonyms>Colorectal Tumors, Carcinomas, large bowel cancer, Colorectal Neoplasm, Carcinoma, Peptidomimetic, human being, Man (Taxonomy), Colorectal Cancer, Neoplasms, Modern, susceptibility to, Colorectal Carcinoma, Colorectal Carcinomas, Cancers, Tumor, Colorectal Tumor, man, cancer of large bowel, autosomal dominant, human, large intestine cancer, Human, cancer of the large intestine, Colorectal, colorectal cancer, colon cancer, Homo sapiens, Modern Man, Neoplasm, cancer of the large bowel, Cell., CRC, Colorectal Cancers, cancer of large intestine, Man, somatic mutation, colorectal (colon or rectal) cancer, Tumors, Cancer</name_synonyms><description_synonyms>Colorectal Tumors, Carcinomas, large bowel cancer, Colorectal Neoplasm, Carcinoma, Peptidomimetic, human being, Man (Taxonomy), Colorectal Cancer, Neoplasms, Modern, susceptibility to, Colorectal Carcinoma, Colorectal Carcinomas, Cancers, Tumor, Colorectal Tumor, man, cancer of large bowel, autosomal dominant, human, large intestine cancer, Human, cancer of the large intestine, Colorectal, colorectal cancer, colon cancer, Homo sapiens, Modern Man, Neoplasm, cancer of the large bowel, Cell., CRC, Colorectal Cancers, cancer of large intestine, Man, somatic mutation, colorectal (colon or rectal) cancer, Tumors, Cancer</description_synonyms></additional><is_claimable>false</is_claimable><name>Transcriptional response to reverse-turn peptidomimetics in human colorectal cancer cells</name><description>Transcriptional response to reverse-turn peptidomimetics in human colorectal cancer cells</description><dates><last_updated>2025-09-24</last_updated><first_public>2021-10-30</first_public></dates><accession>PRJNA734600</accession><cross_references><GEO>GSE176026</GEO><taxon>9606</taxon><PubMed>34877499</PubMed></cross_references></HashMap>